Motus GI Holdings announced that it has received approval from the Israeli Ministry of Health, MOH, Medical Device Division to initiate commercial sales of the Pure-Vu EVS System in Israel. “We are pleased to secure regulatory clearance for the Pure-Vu EVS System in Israel, which is considered an advanced medical system globally and one of the largest markets in this region. Leading healthcare systems in a number of regions in the U.S. and the Veterans Health Administration are currently utilizing the Pure-Vu EVS System. Gaining regulatory approval in various regions of the world supports our strategy to enable strategic partnerships with medical device companies on a global basis,” stated Mark Pomeranz, Chief Executive Officer of Motus GI.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOTS:
- Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu® EVS System
- Motus GI announces purchase agreement for Pure-Vu System from Banner Desert
- Motus GI Announces Purchase Agreement for the Pure-Vu System® from Banner Desert Medical Center
- Motus GI price target lowered to $2.50 from $10 at H.C. Wainwright
- Motus GI Holdings showcases Pure-Vu Gen 4 Gastro, Colon System at IECED